Intervention

Placebo (for 20 μg/kg Group)

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting1

Common conditions1

Lead sponsors shown1

Clinical trials

2 shown

A Study to Evaluate JL18008 in Subject With HIV Immunological Non-RespondersNCT07579741 · 2026-05-26

To Evaluate the Safety of JL18008NCT07629310 · 2024-06-13

Common conditions

HIV Infections2

Leading sponsors

Jecho Biopharmaceuticals Co., Ltd.2

Trial status mix

COMPLETED1

RECRUITING1

Phase mix

PHASE12

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.